Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence.


AIMS Haemostasis interrupts bleeding from disrupted blood vessels by activating platelet aggregation and coagulation. A similar mechanism termed thrombosis generates obstructive thrombi inside diseased arteries. As a consequence of this similarity, current anti-thrombotic agents increase the risk of bleeding. Atherosclerotic plaques produce significant… (More)
DOI: 10.1093/cvr/cvt276


4 Figures and Tables

Slides referencing similar topics